Detection of novel urine markers using immune complexome analysis in bladder cancer patients: A preliminary study

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: Little is known on urine biomarkers that are associated with malignant behavior in patients with bladder cancer (BC). Our aim was to identify BC-related factors in urine samples using our original method “immune complexome analysis”, based on detecting the immune complex (IC). Patients and Methods: Immune complexome analysis was performed using urine samples from 97 BC patients, including 67 with non-muscle invasive BC (NMIBC). Results: Eight IC-antigens were recognized as candidates for BC-related factors from 20,165 proteins. IC-serum albumin, -fibrinogen γ chain, -hemoglobin subunit α, -hemoglobin subunit β, -ceruloplasmin, and fibrinogen β chain were significantly associated with either pathological features and/or outcome. IC-ceruloplasmin was most widely associated with pathological features in all BC patients and lamina propria invasion and urinary tract recurrence in NMIBC. Conclusion: Based on detection of IC-antigens it was demonstrated that six IC-antigens, especially IC-ceruloplasmin, are potential urine biomarkers in BC.

Cite

CITATION STYLE

APA

Aibara, N., Miyata, Y., Araki, K., Sagara, Y., Mitsunari, K., Matsuo, T., … Ohyama, K. (2021). Detection of novel urine markers using immune complexome analysis in bladder cancer patients: A preliminary study. In Vivo, 35(4), 2073–2080. https://doi.org/10.21873/INVIVO.12476

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free